Competition between the brain and testes under selenium-compromised conditions: insight into sex differences in selenium metabolism and risk of neurodevelopmental disease
Gejl M, Sndergaard HM, Stecher C, Bibby BM, Moller N, Botker HE, et al
Keep in mind: Starting in April 2026, Medicare and Medicaid may begin covering GLP-1 medications like Zepbound and Mounjaro more broadly, including for obesity-related use
In the meantime, the TGA is encouraging patients to talk to their doctors to get more information
For a look at how semaglutide results compare, TrimRx has a detailed breakdown of semaglutide timelines as well
Paraventricular thalamic control of food intake and reward: role of glucagon-like Peptide-1 receptor signaling